Global Bovine Mastitis Market Report By Type (Clinical Mastitis, Sub-clinical Mastitis), By Product (Antibiotics, Vaccines, Pain Killers, Others), By Route Of Administration (Intra-mammary, Systemic), By Therapy (Lactating Period, Dry Period, Antibiotics, Teat Sealants), By End User (Veterinary Centers, Hospital, Clinics, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

The global demand for Bovine Mastitis Market is presumed to reach the market size of nearly USD 2.52 BN by 2028 from USD 1.54 BN in 2021 with a CAGR of 7.3% under the study period 2022 - 2028.

Bovine mastitis refers to a medical condition that generally occurs in dairy cows. One of the primary reasons the illness is seen as harmful is because it can affect the cows' milk-secreting tissues. A wide variety of various microorganism species brings on mastitis. They include bacteria, fungi, mycoplasmas and viruses. The disease is generally identified through a red and firm udder lump. This disorder frequently results in blood clots, unpleasant-smelling brown discharge, and milk clots. 

Market Dynamics

The major factor propelling bovine mastitis include the increasing incidence of bovine mastitis. In addition, technological development in the field of drug discovery and advances made for the treatment of bovine mastitis are also positively contributing to market demand. On the downside, the increasing antibiotic resistance and lack of awareness about the disease are the critical factors expected to hinder the growth of the bovine mastitis market. 

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bovine mastitis. The growth and trends of bovine mastitis industry provide a holistic approach to this study. 

Market Segmentation

This section of the bovine mastitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type

• Clinical Mastitis
• Sub-Clinical Mastitis

By Product

• Antibiotics
• Vaccines
• Pain Killers
• Others

By Route Of Administration

• Intra-Mammary
• Systemic

By Therapy

• Lactating Period
• Dry Period
• Antibiotics
• Teat Sealants

By End User

• Veterinary Centers
• Hospital
• Clinics
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Bovine Mastitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Bovine Mastitis Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bovine mastitis market include Zoetis, Merck & Co. Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, Nimrod Veterinary Products Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.